![](https://investorshub.advfn.com/uicon/507416.png?cb=1538015923)
Saturday, January 22, 2022 6:40:17 AM
Analyst Coverage Mackie Research Capital Echelon Wealth Partners Target Price “$0.80” by Mackie Research “$0.50” by Echelon Wealth
TREATMENT FOR VARIOUS CANCERS Planning on initiating Phase 1b study for other cancer indications. Strong upside for growth and valuation.
PowerPoint Presentation Sept 2021
JMO, maybe, maybe not.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM